Shakambri Health Products Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -97.45%
- Profit Growth -240.18%
- Ebitda -181.79%
- Net Worth -94.12%
- Total Assets -10.56%
About Shakambri Health Products
Shakambri Health Products Private Limited (SHPPL) is a Private Limited Indian Non-Government Company incorporated in India on 26 July 2018 (Six years and seven months 1 days old ). Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Mayank Rungta and Anil Rungta serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999MH2018PTC312249
- Company No.
312249
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Jul 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
What products or services does Shakambri Health Products Private Limited offer?
Shakambri Health Products Private Limited offers a wide range of products and services, including Industrial Fabrics and Textiles, Non Woven Fabric, Pharmaceutical Machinery & Equipment, Pharmaceutical Machines.
Who are the key members and board of directors at Shakambri Health Products?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mayank Rungta  | Director | 26-Jul-2018 | Current |
| Anil Rungta | Director | 26-Jul-2018 | Current |
Financial Performance of Shakambri Health Products.
Shakambri Health Products Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 97.45% decrease. The company also saw a substantial fall in profitability, with a 240.18% decrease in profit. The company's net worth observed a substantial decline by a decrease of 94.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shakambri Health Products?
In 2019, Shakambri Health Products had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Shakambri Health Products?
Unlock and access historical data on people associated with Shakambri Health Products, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shakambri Health Products, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shakambri Health Products's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.